Potential Liability, Lack Of Incentives Complicate Cross-Labeling Ventures
This article was originally published in The Gray Sheet
Executive Summary
Industry trade groups should explore incentives such as tax breaks to get drug companies to partner with device firms commercializing novel products, participants suggested at a Jan. 11-12 combo product summit